Cargando…

Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women

BACKGROUND: Inability to conceive is a major problem during reproductive age. This study aimed to describe medical characteristics and different approaches to get better the management of infertility among women referring to some public and private health centers in Morocco. METHODS: Overall, 619 in...

Descripción completa

Detalles Bibliográficos
Autores principales: BENKSIM, Abdelhafid, AIT ADDI, Rachid, ELKHOUDRI, Noureddine, CHERKAOUI, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379602/
https://www.ncbi.nlm.nih.gov/pubmed/30788297
_version_ 1783396123709276160
author BENKSIM, Abdelhafid
AIT ADDI, Rachid
ELKHOUDRI, Noureddine
CHERKAOUI, Mohamed
author_facet BENKSIM, Abdelhafid
AIT ADDI, Rachid
ELKHOUDRI, Noureddine
CHERKAOUI, Mohamed
author_sort BENKSIM, Abdelhafid
collection PubMed
description BACKGROUND: Inability to conceive is a major problem during reproductive age. This study aimed to describe medical characteristics and different approaches to get better the management of infertility among women referring to some public and private health centers in Morocco. METHODS: Overall, 619 infertile women referring to public and private health centers in Marrakech-Safi region were selected by simple random sampling method, between 1 Oct 2013 and 31 Dec 2015. The socio-economic data, demographic characteristics, medical and obstetric variables and types of infertility treatments were simultaneously collected by questionnaire and health record data. The univariate logistic regression analyses were used to determine different infertility treatments. Statistical significance was set at 0.05. RESULTS: The rate of primary and secondary infertility was 67.37%, and 32.63%, respectively. In comparison to secondary infertility, primary infertile women with high socio-economic level and low average age have used many fertility drugs and assisted reproductive technologies (Clomifene citrate (45.01 vs. 29.20%), injectable gonadotropins (09.35 vs. 3.96%), dydrogesterone (35.08 vs. 23.26%), intrauterine insemination (3.83 vs. 0.49%), and in-vitro fertilisation (3.11 vs. 1.48%)). CONCLUSION: The use of infertility’s treatment is limited in Morocco. Outside of medical coverage, the infertility management requires permanent efforts, financial supports, psychological assistance and serious dialogue between all the stakeholders.
format Online
Article
Text
id pubmed-6379602
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-63796022019-02-20 Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women BENKSIM, Abdelhafid AIT ADDI, Rachid ELKHOUDRI, Noureddine CHERKAOUI, Mohamed Iran J Public Health Original Article BACKGROUND: Inability to conceive is a major problem during reproductive age. This study aimed to describe medical characteristics and different approaches to get better the management of infertility among women referring to some public and private health centers in Morocco. METHODS: Overall, 619 infertile women referring to public and private health centers in Marrakech-Safi region were selected by simple random sampling method, between 1 Oct 2013 and 31 Dec 2015. The socio-economic data, demographic characteristics, medical and obstetric variables and types of infertility treatments were simultaneously collected by questionnaire and health record data. The univariate logistic regression analyses were used to determine different infertility treatments. Statistical significance was set at 0.05. RESULTS: The rate of primary and secondary infertility was 67.37%, and 32.63%, respectively. In comparison to secondary infertility, primary infertile women with high socio-economic level and low average age have used many fertility drugs and assisted reproductive technologies (Clomifene citrate (45.01 vs. 29.20%), injectable gonadotropins (09.35 vs. 3.96%), dydrogesterone (35.08 vs. 23.26%), intrauterine insemination (3.83 vs. 0.49%), and in-vitro fertilisation (3.11 vs. 1.48%)). CONCLUSION: The use of infertility’s treatment is limited in Morocco. Outside of medical coverage, the infertility management requires permanent efforts, financial supports, psychological assistance and serious dialogue between all the stakeholders. Tehran University of Medical Sciences 2018-12 /pmc/articles/PMC6379602/ /pubmed/30788297 Text en Copyright© Iranian Public Health Association & Tehran University of Medical Sciences http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
BENKSIM, Abdelhafid
AIT ADDI, Rachid
ELKHOUDRI, Noureddine
CHERKAOUI, Mohamed
Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women
title Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women
title_full Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women
title_fullStr Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women
title_full_unstemmed Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women
title_short Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women
title_sort medical characteristics and therapeutic approaches used to treat primary and secondary infertile women
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379602/
https://www.ncbi.nlm.nih.gov/pubmed/30788297
work_keys_str_mv AT benksimabdelhafid medicalcharacteristicsandtherapeuticapproachesusedtotreatprimaryandsecondaryinfertilewomen
AT aitaddirachid medicalcharacteristicsandtherapeuticapproachesusedtotreatprimaryandsecondaryinfertilewomen
AT elkhoudrinoureddine medicalcharacteristicsandtherapeuticapproachesusedtotreatprimaryandsecondaryinfertilewomen
AT cherkaouimohamed medicalcharacteristicsandtherapeuticapproachesusedtotreatprimaryandsecondaryinfertilewomen